OCR and ECAR were measured in a XFe96 extracellular flux analyzer (Seahorse Bioscience). Cortical neurons were seeded in Agilent Seahorse XF96 cell culture microplate coated poly-l-lysine/laminin and incubated in a CO2 incubator at 37 °C for 12 days before infection with recombinant HSV. After two days, 1 h prior to the assay, growth medium was replaced with XF assay medium containing Seahorse XF DMEM Medium (pH 7.4) (Agilent 103575-100), 10 mM Seahorse XF Glucose (Agilent 103577-100), 1 mM Seahorse XF Pyruvate (Agilent 103578-100), and 1× GlutaMAX (Gibco 35050-061) and the place was placed in a 37 °C incubator without CO2. Basal respiration was calculated by subtracting the average OCR obtained after the third and fourth injections (2 μM Antimycin A+ 2 μM Piericidin A, and 50 mM 2-deoxy-d-glucose (2-DG), respectively) from the baseline OCR. Maximal respiration capacity was calculated by subtracting the average OCR obtained after the third and fourth injections from OCR obtained after carbonyl cyanide m-chlorophenyl hydrazone (CCCP) (12 μM) injection. ATP-production coupled respiration was calculated by subtracting the OCR obtained after injecting 2 μM oligomycin A from the basal OCR. Basal ECAR was calculated by subtracting the average non-glycolytic ECAR obtained after 2-DG injection from the baseline ECAR. Finally, the glycolytic capacity was calculated by subtracting the average non-glycolytic ECAR from ECAR obtained after injecting 2 μM oligomycin A.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.